325694-03-9
WAY-313356
115453-99-1
CB-7921220
328998-53-4
INS3-54A18
955371-66-1
VK-II-36
2991059-69-7
Letermovir impurity 13
433212-75-0
SSAA09E1
1438416-21-7
MJN110
622795-76-0
PIP-199
281224-40-6
M-31850
1832671-96-1
Y06036
2991059-71-1
Letermovir impurity
1695869-28-3
Letermovir impurity
2089293-61-6
NAcM-OPT
791840-86-3
NLRP3/AIM2-IN-2
1380593-17-8
ST1237
1809170-59-9
UniPR1331
2641824-60-2
(S)-Methyl (S)-3-(4-((tert-butoxycarbonyl)morpholin-2-yl)-2-((benzyloxycarbonyl)amino)propanoate
292168-79-7
KY1220
2864383-32-2
Ethyl (2R,3R)-3-cyclopropyl-1-methylaziridine-2-carboxylate
475086-28-3
Selexipag impurity
Order
2030-63-9
N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropyliaino)phenazin-2-amine (Clofazimine)
1832671-96-1, CAS No. 1832671-96-1,CasNo 1832671-96-1,cas 1832671-96-1
Y06036